CN1275606C - 西蒙得木油的医药用途 - Google Patents
西蒙得木油的医药用途 Download PDFInfo
- Publication number
- CN1275606C CN1275606C CNB021412995A CN02141299A CN1275606C CN 1275606 C CN1275606 C CN 1275606C CN B021412995 A CNB021412995 A CN B021412995A CN 02141299 A CN02141299 A CN 02141299A CN 1275606 C CN1275606 C CN 1275606C
- Authority
- CN
- China
- Prior art keywords
- oil
- simmondsia
- treatment
- jojoba oil
- simonder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/004—Preparations used to protect coloured hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Medical Informatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
Abstract
本发明涉及西蒙得木油及其提取方法,以及含有西蒙得木油的组合物及其医药用途,所述西蒙得木油的特征在于对皮肤和粘膜无刺激和无过敏作用,所述西蒙得木油具有润滑、润湿和润肤,以及抗菌、抗炎和抗氧化性质,所述西蒙得木油具有较高复原性,改善血液循环,和对角质层较高穿透性的性质。
Description
本发明涉及西蒙得木油及其提取方法,以及含有西蒙得木油的组合物及其医药用途。
现有技术
西蒙得木油可用于发动机的润滑,并可加入化妆品制剂中。技术缺乏的问题和要点
这里不存在问题。西蒙得木油的在先应用不涉及本发明想要保护的新用途。
发明详细说明
天然西蒙得木油是从西蒙得木灌木{Simmondsia Chinensis(LINK)Schnieder}的种子中提取得到的。所述西蒙得木油由单不饱和长链脂肪酸和脂肪醇的直链酯构成,并且所述西蒙得木油平均碳链总长为42个碳原子,因此其化学分类为液体蜡。
所述西蒙得木油完全由高分子量的直链单烯酸和单烯醇形成的酯构成。
所述的不饱和酸是二十烷酸(C20)和二十二烷酸(C22)的混合物,其中含有少量棕榈油酸(C18)和油酸(C16)。所述的不饱和醇是二十烷醇和二十二烷醇的混合物,其中含有少量二十六烷醇和低分子量醇。
所述西蒙得木油是非挥发性的,并且不会发生酸败,这部分归因于其中存在的微量组分生育酚(天然抗氧剂),主要还是因其蜡状结构(其仅含一个醇基团,因此不会发生氧化,从而不会出现酸败)。此外,研究表明西蒙得木油具有可增进在角质层中渗透作用的6项普遍因素:低粘度,高不饱和度,低皂化数,碳链长度短,卵磷脂含量低(西蒙得木油不含卵磷脂),直链分子和支链酯。
所述西蒙得木油有助于避免皮肤早老化的两项重要因素:干燥和脂类过氧化。所述西蒙得木油可用作优异的非隔离性滋润剂,所述滋润剂可促进皮肤的弹性和柔软性。同时,所述西蒙得木油特殊的不粘腻的涂布性和光滑性可获得极富轻软光滑的使用感。
所述西蒙得木油的特征在于其中50%含量的部分是不可皂化的(三萜烯醇和植物甾醇),而其他植物油仅含2-3%不可皂化部分,不可皂化部分用于皮肤时可促进弹性蛋白的形成,从而增进皮肤的光泽、弹性和完整性。此外,其具有皮肤保护性,抗过敏性,抗感染性,可产生细胞刺激作用,具有皮肤再生作用和抗炎作用。
经证实,所述西蒙得木油具有抗炎作用和抗微生物作用。包括金黄色酿脓葡萄球菌和绿脓假单胞菌在内的5种最常见的细菌、以及真菌白色念珠菌都不能在西蒙得木油中生长。
所述西蒙得木油的pH值平衡,并能表现出对干燥和受损皮肤的有益效果。
西蒙得木油的提取
1、西蒙得木种子的含油量为50-55%(重量)。
2、提取西蒙得木油的第一步是在从1Ton/Inch逐渐达到35-38Ton/Inch的压力下对碎化的种子进行压榨。
3、由第一步制得占种子重量26-28%(重量)的油,其被称为第一步油,所述第一步油适用于医药应用。
4、对经压榨的种子残渣进行分离和研磨,然后在高至100Ton/Inch的压力下再次榨取,提取得到第二步油,所述第二步油可应用于化妆品或其他领域。所得到的这种油也称为第二步油。
5、所述油(第一步油和第二步油)经一定时间淘析。
6、通过4级过滤器对所述油进行过滤。然后对所得的油进行一定时间的淘析。
7、采用比第一次使用的所述4级过滤器级别更高的4级过滤器对所得的油进行再过滤,获得医用的最终油。
8、第一步所提取的油的性能比普通油优异,特别是表现在医药效果上。
新主题:
西蒙得木油可用于治疗以下疾病:
A-皮肤病:
A-1其于水杨酸共用可有效用于牛皮癣、头屑、痤疮和鳞癣病的治疗。
A-2其与氧化锌共用可有效治疗尿布皮炎、皮疹、过敏性皮炎和念珠菌感染。
A-3昆虫叮咬的治疗。
A-4脚趾真菌感染的治疗。
A-5保护皮肤免受非传染性致敏材料如液体洗涤皂的作用。
A-6其可有效用于兽疥癣的治疗。
A-7治疗一度烧伤和阳光灼伤。
A-8在日晒过程中保护皮肤免受紫外线损伤。
A-9用于伤口的第一助剂,以及用于治疗发炎的伤口,并以促进愈合为首要目的。
A-10褥疮的治疗。
A-11其有助于治疗斑秃和rogenetica。
A-12抑制头虱。
A-13其可有效用于单纯性口疮(唇疮疹)的治疗。
A-14其可有效用于糖尿病性损伤特别是糖尿病性脚癣(diabeticfoot)的治疗。
B-西蒙得木油可用于治疗牙龈炎和牙痛:
B-1其与盐酸利多卡因共用可有效治疗周期性口疮性溃疡。
B-2其可用于牙膏这用于治疗牙龈炎和改善牙周状况。
B-3其与氧化锌共用可有效用于牙齿的暂时填充。
B-4其可有效用于作为化疗和放疗副作用的干槽症的治疗。
C-风湿痛和关节炎:
C-1治疗和缓解多发性关节炎、风湿痛、关节痛和脊椎炎。
C-2增进理疗疗效,并且除消除应力和痉挛之外还有助于身体恢复其物理机能。
D-其可有效用于外耳炎和中耳炎的治疗:
E-对眼病的治疗:
E-1其可有效用于血栓症的治疗。
F-普通外科:
F-1其可以栓剂形式有效用于急慢性肛裂和肛瘘的治疗。
F-2前列腺炎的治疗。
F-3冻伤(Hiemorroids)(二度)的治疗.
F-4早期静脉曲张的治疗。
G-妇产科:
G-1以阴道栓的形式用于阴道炎的治疗。
G-2用于缓解痛经。
G-3用于乳头裂的治疗,并能促进愈合。
应用方法:
可通过加入其他药物应用西蒙得木油。用于使新药达到更好的疗效而不产生副作用。实施例如下:
1-将含有10%西蒙得木油和0.5%盐酸利多卡因的组合物用于治疗口腔粘膜炎症和因长期使用抗生素造成的症状。
2-将含有50%西蒙得木油和2%水杨酸的组合物的软膏剂用于治疗痤疮、牛皮癣、头屑、皮脂溢(皮脂腺的异常过度分泌)和鳞癣(表皮角质层变硬并持续脱皮)。
3-将含有50%西蒙得木油和8%氧化锌的组合物用于治疗皮疹和过敏性皮炎。
4-将含有20%西蒙得木油的栓剂用于治疗肛裂。
5-将含有20%西蒙得木油的阴道栓用于治疗非传染性阴道炎。
由上述有益效果可以清楚地知道,对于各种形式和情况,西蒙得木油在治疗各种疾病时均不会对人体和环境产生任何副作用。
Claims (1)
1、一种西蒙得木油的提取方法,所述方法在从1Ton/Inch逐渐达到35~38Ton/Inch的压力下,通过对西蒙得木已碎化的种子进行压榨制得第一步油,然后残渣二再经碎化,并在高至100Ton/Inch的压力下再次榨取制得第二步油,所述第一步油和第二步油经过不同级别过滤器的过滤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EGNO.750 | 2001-07-07 | ||
EG20010750 | 2001-07-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1395964A CN1395964A (zh) | 2003-02-12 |
CN1275606C true CN1275606C (zh) | 2006-09-20 |
Family
ID=8163780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021412995A Expired - Fee Related CN1275606C (zh) | 2001-07-07 | 2002-07-05 | 西蒙得木油的医药用途 |
Country Status (6)
Country | Link |
---|---|
US (4) | US6846499B2 (zh) |
EP (1) | EP1281401A3 (zh) |
JP (1) | JP2003063978A (zh) |
CN (1) | CN1275606C (zh) |
MA (1) | MA25696A1 (zh) |
TN (1) | TNSN02063A1 (zh) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138134B2 (en) * | 2001-12-18 | 2006-11-21 | Arizona Health Consulting Group, Llc | Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels |
WO2004004454A2 (en) * | 2002-07-08 | 2004-01-15 | Isca Technologies | Method of producing vertebrate host mimic with modified lipid based media |
US7025957B2 (en) * | 2002-09-06 | 2006-04-11 | Desert Whale Jojoba Company | Composition and method to whiten skin |
AU2003266142A1 (en) * | 2002-09-12 | 2004-04-30 | Biosyn, Inc. | Mucus formulation for mucosal surfaces and uses thereof |
US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
FR2856304B1 (fr) * | 2003-06-20 | 2006-03-03 | Natural Product Consulting | Composition pour la prevention des infections du systeme urinaire |
US20050202097A1 (en) * | 2004-03-12 | 2005-09-15 | Melbj Holdings, Llc, Florida | Lubricant for the ocular surface |
US8455016B2 (en) * | 2004-03-12 | 2013-06-04 | Melbj Holdings, Llc | Treatment for meibomian gland dysfunction or obstruction |
AU2005260090B2 (en) * | 2004-03-12 | 2008-06-05 | Melbj Holdings, Llc | Lubricant for the ocular surface |
AU2006337161B2 (en) | 2006-02-03 | 2012-06-07 | Obagi Cosmeceuticals Llc | Anti-aging treatment using copper and zinc compositions |
US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
JP2007238488A (ja) * | 2006-03-07 | 2007-09-20 | Kose Corp | 乳化型皮膚外用剤 |
US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
US20100210932A1 (en) * | 2007-03-20 | 2010-08-19 | Bayer Healthcare Llc | Method of analyzing an analyte |
WO2008121355A1 (en) * | 2007-03-29 | 2008-10-09 | International Flora Technologies, Ltd. | Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations |
JP4891207B2 (ja) * | 2007-11-27 | 2012-03-07 | 大洋香料株式会社 | 抗菌剤及びそれを含有する皮膚外用剤 |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
FR2940291B1 (fr) | 2008-12-23 | 2012-12-21 | Isp Investments Inc | Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant |
FR2940125B1 (fr) | 2008-12-23 | 2013-03-22 | Isp Investments Inc | Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase |
WO2010085753A1 (en) | 2009-01-23 | 2010-07-29 | Jr Chem, Llc | Rosacea treatments and kits for performing them |
FR2944446B1 (fr) * | 2009-04-15 | 2013-08-16 | Isp Investments Inc | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant |
FR2944526B1 (fr) | 2009-04-15 | 2013-05-10 | Isp Investments Inc | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere |
US8933036B2 (en) | 2009-04-15 | 2015-01-13 | Isp Investments Inc. | Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair |
FR2944445B1 (fr) * | 2009-04-15 | 2013-08-16 | Isp Investments Inc | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant |
BR112012024289A2 (pt) | 2010-03-26 | 2017-07-18 | Galderma Res & Dev | "método para fornecer um tratamento seguro e efetivo do eritema e composição de gel tópica" |
KR20130010122A (ko) | 2010-03-26 | 2013-01-25 | 갈데르마 리써어치 앤드 디벨로프먼트 | 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물 |
AR076729A1 (es) | 2010-06-01 | 2011-07-06 | Univ Nac De Cordoba | Procedimiento para la obtencion de una dispersion acuosa de alcoholes y acidos a partir de aceite de jojoba, procedimientos para la obtencion de aceite de jojoba autoemulsionado, dispersiones acuosas y emulsiones de aceite de jojoba en las mismas y composiciones farmaceuticas o cosmeticas que las co |
ES2498217T5 (es) | 2010-10-21 | 2018-03-19 | Galderma S.A. | Composición en forma de gel basada en brimonidina |
US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
EP2708021B1 (en) | 2011-05-12 | 2019-07-10 | DePuy Synthes Products, Inc. | Image sensor with tolerance optimizing interconnects |
KR102020691B1 (ko) * | 2011-11-30 | 2019-09-10 | 아이.비.알.이즈레일리 바이오테크놀로지 리서치 엘티디. | 피부 장벽 기능을 개선시키는 데 유용한 호호바 추출물 |
ITRM20120174A1 (it) * | 2012-04-23 | 2013-10-24 | Aboca Spa Societa Agricola | Nuove composizioni per il trattamento delle ferite croniche. |
JP6526560B2 (ja) | 2012-07-26 | 2019-06-05 | デピュー シンセス プロダクツ, インコーポレーテッドDePuy Synthes Products, Inc. | 光が不十分な環境での連続的なビデオ |
EP2877079B1 (en) | 2012-07-26 | 2021-04-21 | DePuy Synthes Products, Inc. | Camera system with minimal area monolithic cmos image sensor |
CN104619237B (zh) | 2012-07-26 | 2018-03-30 | 德普伊辛迪斯制品公司 | 光不足环境中的ycbcr脉冲调制的照明方案 |
US10188672B2 (en) * | 2012-12-12 | 2019-01-29 | Orbis Health Solutions Llc | Compositions and methods for tissue regeneration |
EP2967294B1 (en) | 2013-03-15 | 2020-07-29 | DePuy Synthes Products, Inc. | Super resolution and color motion artifact correction in a pulsed color imaging system |
JP6422937B2 (ja) | 2013-03-15 | 2018-11-14 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | 光制御された環境において感知する内視鏡 |
US9777913B2 (en) | 2013-03-15 | 2017-10-03 | DePuy Synthes Products, Inc. | Controlling the integral light energy of a laser pulse |
EP2967286B1 (en) | 2013-03-15 | 2021-06-23 | DePuy Synthes Products, Inc. | Minimize image sensor i/o and conductor counts in endoscope applications |
US10517469B2 (en) | 2013-03-15 | 2019-12-31 | DePuy Synthes Products, Inc. | Image sensor synchronization without input clock and data transmission clock |
EP3119265B1 (en) | 2014-03-21 | 2019-09-11 | DePuy Synthes Products, Inc. | Card edge connector for an imaging sensor |
JP2020502099A (ja) * | 2016-12-16 | 2020-01-23 | アーアーコー アーベー(パブリーク)Aak Ab(Publ) | ペトロラタム代替調合物 |
WO2021013315A1 (en) * | 2019-07-22 | 2021-01-28 | Mostafa Mariam Mohamed Kamel | Ointment for diabetic foot ulcer treatment |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4512978A (en) * | 1980-01-24 | 1985-04-23 | Inwood Louis R | Dermatological composition useful in the treatment of psoriasis |
US4381296A (en) * | 1980-06-23 | 1983-04-26 | Tinnell James E | Treatment for herpes virus |
US4591602A (en) * | 1982-04-16 | 1986-05-27 | James H. Brown | Ozonide esters and topical compositions containing same |
JPS59225111A (ja) * | 1983-06-07 | 1984-12-18 | Kao Corp | 肛門周辺部の清浄・清拭剤組成物 |
JPS59227815A (ja) * | 1983-06-08 | 1984-12-21 | Kao Corp | 皮膚清浄・清拭剤組成物 |
US4759798A (en) * | 1983-10-19 | 1988-07-26 | Nostitz F Von | Process for the preparation of dental-technical, dental-medical and medical molding and lining materials |
US4585656A (en) * | 1984-08-20 | 1986-04-29 | Rosenthal Harold R | Treatment of herpes |
DE3811081A1 (de) * | 1988-03-30 | 1989-10-12 | Schering Ag | Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut |
DE3836971C1 (zh) * | 1988-10-31 | 1990-05-17 | Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De | |
JPH0816051B2 (ja) * | 1988-12-07 | 1996-02-21 | エスエス製薬株式会社 | 徐放性坐剤 |
JPH04346928A (ja) * | 1991-05-24 | 1992-12-02 | Doujin Iyaku Kako Kk | 坐剤 |
WO1993010756A1 (en) * | 1991-11-25 | 1993-06-10 | Richardson-Vicks, Inc. | Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
US5516923A (en) * | 1992-04-27 | 1996-05-14 | Agritech International | Extracting oil from oil bearing plant parts |
JPH08509202A (ja) * | 1992-07-08 | 1996-10-01 | ディアノルム―ゲレーテ・ゲー・マイエルホファー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | リポソーム、それを調製する方法及び薬調製におけるその用途 |
JP3496967B2 (ja) * | 1993-12-28 | 2004-02-16 | 御木本製薬株式会社 | 抗プラスミン剤 |
FR2714831B1 (fr) * | 1994-01-10 | 1996-02-02 | Oreal | Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés. |
JPH0892027A (ja) * | 1994-09-20 | 1996-04-09 | Shiseido Co Ltd | にきび用固形粉末外用剤 |
US6365131B1 (en) * | 1997-10-31 | 2002-04-02 | J. B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
US5981499A (en) * | 1998-02-20 | 1999-11-09 | Atlantic Biomed Corporation | Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
US20010014316A1 (en) * | 1999-02-11 | 2001-08-16 | Marie Harbeck | Liquid cleansing composition |
US20010005509A1 (en) * | 1999-02-11 | 2001-06-28 | Marie Harbeck | Foot cream composition |
US20010001666A1 (en) * | 1999-02-11 | 2001-05-24 | Marie Harbeck | Liquid skin treatment |
US6558710B1 (en) * | 1999-06-14 | 2003-05-06 | Helen Rebecca Godfrey | Topical zinc compositions and methods of use |
DE19939836A1 (de) * | 1999-08-21 | 2001-02-22 | Beiersdorf Ag | Wasserhaltige kosmetische oder pharmazeutische Stifte |
US20010046526A1 (en) * | 2000-04-19 | 2001-11-29 | C-Quest | Treatment of fungal infections |
US6582736B2 (en) * | 2001-03-23 | 2003-06-24 | Terra De Sol | Therapeutic oil composition |
US20020187165A1 (en) * | 2001-05-15 | 2002-12-12 | Joseph F. Long | Composition for female sexual arousal |
US6893648B2 (en) * | 2002-01-04 | 2005-05-17 | Harold Mermelstein | Composition and method for treatment of vaginal dryness |
US6579543B1 (en) * | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
-
2002
- 2002-06-28 TN TNTNSN02063A patent/TNSN02063A1/en unknown
- 2002-06-29 EP EP02014495A patent/EP1281401A3/en not_active Withdrawn
- 2002-07-03 US US10/189,888 patent/US6846499B2/en not_active Expired - Fee Related
- 2002-07-04 MA MA26720A patent/MA25696A1/fr unknown
- 2002-07-05 JP JP2002198017A patent/JP2003063978A/ja active Pending
- 2002-07-05 CN CNB021412995A patent/CN1275606C/zh not_active Expired - Fee Related
-
2004
- 2004-03-04 US US10/792,632 patent/US20040170712A1/en not_active Abandoned
- 2004-03-04 US US10/792,611 patent/US20040170711A1/en not_active Abandoned
- 2004-03-04 US US10/792,610 patent/US20040170710A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1281401A3 (en) | 2003-06-25 |
US20040170712A1 (en) | 2004-09-02 |
CN1395964A (zh) | 2003-02-12 |
US20040170711A1 (en) | 2004-09-02 |
US6846499B2 (en) | 2005-01-25 |
US20030008022A1 (en) | 2003-01-09 |
MA25696A1 (fr) | 2003-04-01 |
TNSN02063A1 (en) | 2005-12-23 |
US20040170710A1 (en) | 2004-09-02 |
EP1281401A2 (en) | 2003-02-05 |
JP2003063978A (ja) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1275606C (zh) | 西蒙得木油的医药用途 | |
AU752204B2 (en) | Substance mixture for topical application comprising olive oil and honey | |
JP4861606B2 (ja) | 皮膚炎を治療するプロアントシアニジンを含む局所用医薬組成物 | |
KR20060076254A (ko) | 플러렌 클러스터를 함유하는 화장품용 조성물 | |
CN106606798A (zh) | 一种医用透明质酸生物修复贴及其制备方法 | |
EP1140006B1 (de) | Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure | |
EP2364713B1 (en) | Dermatological composition for use in the treatment of skin burns, skin diseases and infected wounds | |
CN112867540A (zh) | 用于组织和骨再生的臭氧化的植物治疗组合物 | |
WO2001019365A1 (en) | Pharmaceutical and/or cosmetical compositions | |
US20190216871A1 (en) | Diabetic foot cream | |
JP2006520769A (ja) | 乾燥肌及び鱗屑肌のための、及び乾癬、皮膚炎、及び湿疹の治療のためのトール油脂肪酸及び植物油を含むスキンケア製品 | |
CN111617199A (zh) | 复方精油配方 | |
WO2002058640A1 (en) | Topical therapeutic skin care system | |
RU2405534C1 (ru) | Крем-гель противоугревой | |
CA2627021A1 (en) | Combination natural source/local anesthetic/dual component penetration enhancer topical formulation useful for treating pain, itching and/or inflammation of the skin | |
CN114028282B (zh) | 一种控油净肤组合物及其制备方法和应用 | |
CN103462873B (zh) | 一种美容养颜的护肤品及其制备方法 | |
TR202009156A2 (tr) | Yara iyileşmesini ve iltihabın azalmasını destekleyici bitkisel takviye kremi | |
WO2016086280A1 (pt) | Composição dermatológica e seu uso | |
EP3458019B1 (de) | Erzeugnis zum therapieren und vorbeugen von burnout-syndromen der kopfhaut und der haut | |
KR20110008978A (ko) | 대추나무잎을 이용한 비누 | |
CN1393221A (zh) | 一种治疗痤疮的药液 | |
Liu | 7 Surprising Benefits of the AMAZING Aloe Vera Plant! | |
CN112999116A (zh) | 一种嘴唇防裂组合物 | |
KR20230147899A (ko) | 두피 유분량 감소 및 두피 소취용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |